Mymetics Corp.

Common Stock SEC Reporting - Current
Verified Company Profile 12/09/2016
Contact Info
  • co Mymetics S.A.
  • Biopole
  • Route de la Corniche, 4
  • Epalinges 1066
  • Switzerland

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 10-K
CIK 0000927761
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: DE, USA
Year of Inc. 1994
Employees 10 a/o Dec 31, 2015
Company Officers/Contacts
Ronald Kempers President, CEO
Sylvain Fleury CSO
Toon Stegmann Chief Scientific Officer
Carmelina Mahrer Director, Fin.
Company Directors
Ulrich Burkhard
Thomas Staehelin
Ernest M. Stern
Service Providers
Accounting/Auditing Firm
Peterson Sullivan LLP
601 Union St.
Suite 2300
Seattle, WA, 98101
United States
Securities Counsel
Akerman LLP
One SE 3rd Avenue
Suite 2700
Miami, FL, 33131
United States
Investor Relations Firm
Dynamics Group SA
Rue de Caroubiers 21
CH 1227 Carouge
Company History
  • Formerly=ICHOR Corp. until 7-01
  • Formerly=PDG Remediation, Inc. until 1-97
MYMX Security Details
Share Structure
Market Value1 $6,682,668 a/o Apr 28, 2017
Authorized Shares 1,000,000,000 a/o Mar 29, 2016
Outstanding Shares 303,757,622 a/o Nov 14, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 91,064,968 a/o Mar 29, 2016
Par Value 0.01
Transfer Agent(s) Verified by Transfer Agent
Interwest Transfer Co., Inc.
Shareholders of Record 650 a/o Mar 30, 2017
Short Selling Data
Short Interest 9,200 (36.03%)
Mar 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security